Stamford, CT -- (SBWIRE) -- 01/20/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Simon Property Group Inc (NYSE:SPG), Gentium S.p.A. (ADR) (NASDAQ:GENT), Northern Trust Corporation (NASDAQ:NTRS), Amicus Therapeutics, Inc. (NASDAQ:FOLD).
Simon Property Group Inc (NYSE:SPG) opened its last trade at the price of $157.36. Its closing price was $156.71 after losing -0.44% for the day. The company traded with the total volume of 1.57 million shares, while its average trading volume remained 1.45 million shares. The beta of this stock stands at 1.35. Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, and management of properties. It primarily invests in regional malls, Premium Outlets, The Mills, and community/lifestyle centers to create its portfolio.
Has SPG Found The Bottom and Ready To Move Up? Find Out Here
Gentium S.p.A. (ADR) (NASDAQ:GENT) percentage change plunged -0.04% to close at $56.97 with the total traded volume of 1.32 million shares, along with average volume of 337,808.00 shares. The 52 week range of the stock remained $6.96 - $59.25, while its day lowest price was $56.92. The share price hit the day highest price of $57.00. Gentium S.p.A., a biopharmaceutical company, engages in the research and development of drugs derived from DNA and DNA molecules. The company develops and manufactures defibrotide, an investigational drug based on a mixture of single-and double-stranded DNA extracted from pig intestines for the treatment and prevention of veno-occlusive disease (VOD).
Has GENT Found The Bottom And Ready To Gain Momentum? Find Out Here
Northern Trust Corporation (NASDAQ:NTRS) traded on volume of 1.57 million shares in the last session against average volume of 1.25 million shares. The company started its trading session with the price of $61.91 and closed at $60.71 by scoring -0.56%. Northern Trust Corporation, through its subsidiaries, provides asset servicing, fund administration, asset management, fiduciary, and banking solutions worldwide. Its Corporate and Institutional Services unit provides asset servicing and related services, including cash management, investment risk and performance analytical services, investment operations outsourcing, and transition management and commission recapture, as well as global master trust and custody, trade settlement, and reporting.
Why Should Investors Buy NTRS After the Recent Fall? Just Go Here and Find Out
Amicus Therapeutics, Inc. (NASDAQ:FOLD) started its last trading session with the price of $2.48 and closed at $2.72 by scoring +10.57%. The stock traded with total volume of 1.31 million shares, while the average trading volume remained 363,697.00 shares. The beta value of this stock stands at 0.99. Day range for the stock was $2.47 - $2.90. Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs known as pharmacological chaperones. It develops pharmacological chaperones as next-generation medicines for a range of rare and orphan diseases with a focus on improved therapies for lysosomal storage disorders.
For How Long FOLD will Fight for Profitability? Read This Trend Analysis report
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)